Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Digestive system drugs>Antacid and Mucosal protective Drugs>Proglumide
Proglumide
  • Proglumide

Proglumide NEW

Price $33 $47 $89
Package 25mg 50mg 100mg
Supply Ability: 10g
Update Time: 2026-06-10

Product Details

Product Name: Proglumide CAS No.: 6620-60-6
Purity: 99.40% Supply Ability: 10g
Release date: 2026/06/10

Product Introduction

Bioactivity

NameProglumide
DescriptionProglumide (Binoside) is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
StorageKeep away from moisture,Keep away from direct sunlight,Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information10% DMSO+90% Saline : 10 mg/mL (29.9 mM), Suspension.
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (5.98 mM), Sonication is recommended.
DMSO : 250 mg/mL (747.59 mM)
KeywordsXylamide | TBARS | SOD | secretion | Proglumide | Inhibitor | inhibit | GST | GSH | gastric | CNS | Cholecystokinin Receptor | CCK-B | CCK-A | CCK Receptor | CAT | Binoside | antioxidant | antiepileptic
Inhibitors RelatedPHA-767491 | GV-150013X | CCKBR agonist-2 | (Iso)-FK-480 | Itriglumide | Caerulein, desulfated | GV150013 | Lintitript | N-Cbz-DL-tryptophan | A-65186 | Pranazepide | Spiroglumide
Related Compound LibrariesFailed Clinical Trials Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | ReFRAME Related Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Anti-Aging Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
VIP6Y
RongNa Biotechnology Co.,Ltd
2026-07-05
VIP6Y
Sinoway Industrial co., ltd.
2026-07-02
$33.00
VIP6Y
TargetMol Chemicals Inc.
2026-06-10
$10.00
VIP6Y
Hebei Chuanghai Biotechnology Co,.LTD
2026-05-28
$121.00
VIP6Y
Baoji Guokang Healthchem Co., Ltd.
2026-05-15
Hebei Chuanghai Biotechnology Co., Ltd
2025-03-11
$150.00
Liaoning Pharmaceutical Innovation Co., Ltd
2024-03-22
$35.00
Sigma Audley
2024-03-15
$5.00
XINGTAI XINGJIU NEW MATERIAL TECHNOLOGY CO., LTD
2023-03-27
$15.00
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-09

TargetMol Chemicals Inc.

4YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY